Photofunctionalization With UVC

NCT06724107 · tracked via the Priya Life Science Spain tracker

Sponsor

Universidad Complutense de Madrid

Phase

Not applicable

Started

2024-12-12

Last updated

2024-12-09

Condition(s) studied

Implant Site Reaction

Investigational drug(s) / intervention(s)

UVC

UVC: It is proposed to evaluate and compare the ISQ at 1 week, 2 weeks, 3 weeks and 4 weeks in patients undergoing implant placement surgery by comparing photofunctionalised (study group) and non-photofunctionalised (control group) implants in both native bone and grafted bone. To assess whether immediate loading can be carried out before 4 weeks and how long the waiting time for implant loading can be reduced, by performing predictability curves.

Study summary

Summary:

Objective: The general objective is to compare the placement of standard implants with a surface photofunctionalization technique based on ultraviolet C radiation (UVC), having as working hypothesis that this photofunctionalization will accelerate the bone apposition on the implant surface and increase the amount of bone that binds to the implant, making it possible to load these photofunctionalized implants in less time.

Design: Pilot, clinical, randomized, prospective, controlled, single-center, prospective study.

Scope of the study: Master's Degree in Oral Surgery and Implantology. Faculty of Dentistry. Complutense University of Madrid.

Subjects of the study: patients attending the Master's Degree in Oral Surgery and Implantology for rehabilitation with dental implants, regardless of the sector in which they have missing teeth.

Key words: ISQ (implant stability quotient), inmediate loading, UVC, dental implants.

Eligibility

Sex

ALL

Min age

18 Years

Max age

65 Years

Healthy volunteers

Accepted

Inclusion Criteria: * Patients over 18 years of age. * Patients requiring dental implant surgery with or without bone or soft tissue regeneration surgery. * Acceptance of the informed consent document. Exclusion Criteria: * Subjects with systemic diseases leading to untreated or uncontrolled haemostasis or coagulation disturbances. * Subjects with active infectious diseases (tuberculosis, HIV, syphilis, hepatitis, etc). * Patients under pharmacological treatment with monoclonal antibodies, bisphosphonates, chemotherapy or prolonged treatment with corticoids. * Patients with alcoholism or drug addiction. * Pregnant or breastfeeding women.

Primary outcome measure(s)

Bone regeneration — 3 months
Bone implant contact (BIC) Histotogic parameter in percentage

Trial sites (1)

Facility	City	Region	Status
Jesus Torres	Madrid	Spain	Recruiting

More Universidad Complutense de Madrid trials in Spain

Clinical Evaluation of Resin Matrix Ceramic Posterior Crowns Recruiting

Dry Needling or Percutaneous Electrolysis for Managing Myofascial Trigger Points? Starting soon

Acute Effects of Active Breaks and Physically Active Learning in University Students Starting soon

Optimization of Surgical Hand Preparation Using Sorbectol Recruiting

Effect on Periodontal Phenotype of Flapless Piezoincission During Orthodontic Treatment Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06724107 on ClinicalTrials.gov ↗ ← All trials in Spain